Below are the most recent publications written about "Factor V" by people in Profiles.
-
Yamanishi M, Nishimi Y, Usui M, Miki K, Imashuku S. Acquired Factor V Deficiency Associated with CFPM Administration. Clin Lab. 2019 Oct 01; 65(10).
-
Klarin D, Lynch J, Aragam K, Chaffin M, Assimes TL, Huang J, Lee KM, Shao Q, Huffman JE, Natarajan P, Arya S, Small A, Sun YV, Vujkovic M, Freiberg MS, Wang L, Chen J, Saleheen D, Lee JS, Miller DR, Reaven P, Alba PR, Patterson OV, DuVall SL, Boden WE, Beckman JA, Gaziano JM, Concato J, Rader DJ, Cho K, Chang KM, Wilson PWF, O'Donnell CJ, Kathiresan S, Tsao PS, Damrauer SM. Genome-wide association study of peripheral artery disease in the Million Veteran Program. Nat Med. 2019 08; 25(8):1274-1279.
-
Alhazzani AA, Kumar A, Selim M. Association between Factor V Gene Polymorphism and Risk of Ischemic Stroke: An Updated Meta-Analysis. J Stroke Cerebrovasc Dis. 2018 May; 27(5):1252-1261.
-
Maryamchik E, Rosenbaum MW, Van Cott EM. Rivaroxaban Causes Missed Diagnosis of Protein S Deficiency but Not of Activated Protein C Resistance (Factor V Leiden). Arch Pathol Lab Med. 2018 Jan; 142(1):70-74.
-
Lang J, Vera D, Cheng Y, Tang H. Modeling Dengue Virus-Hepatic Cell Interactions Using Human Pluripotent Stem Cell-Derived Hepatocyte-like Cells. Stem Cell Reports. 2016 09 13; 7(3):341-354.
-
Smock KJ, Plumhoff EA, Meijer P, Hsu P, Zantek ND, Heikal NM, Van Cott EM. Protein S testing in patients with protein S deficiency, factor V Leiden, and rivaroxaban by North American Specialized Coagulation Laboratories. Thromb Haemost. 2016 07 04; 116(1):50-7.
-
Van Cott EM, Khor B, Zehnder JL. Factor V Leiden. Am J Hematol. 2016 Jan; 91(1):46-9.
-
Plompen EP, Darwish Murad S, Hansen BE, Loth DW, Schouten JN, Taimr P, Hofman A, Uitterlinden AG, Stricker BH, Janssen HL, Leebeek FW. Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population: The Rotterdam Study. J Hepatol. 2015 Dec; 63(6):1459-65.
-
Diakite B, Hamzi K, Hmimech W, Nadifi S. First study of C2491T FV mutation with ischaemic stroke risk in Morocco. J Genet. 2015 Jun; 94(2):313-5.
-
Kadauke S, Khor B, Van Cott EM. Activated protein C resistance testing for factor V Leiden. Am J Hematol. 2014 Dec; 89(12):1147-50.